Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Jul 27, 2011

Premium

Verinata Health has tapped Noah Nasser, Suzanne Yokota, and Xitong Li to develop its next-generation sequencing-based fetal diagnostic testing business.

Nasser, who formerly was a business unit manager for molecular diagnostics at Quidel, will be Verinata's vice president of sales and market development. Yokota, who will be Verinata's new VP of marketing and commercial operations, started with the company last year and formerly was commercial director at Satoris, prior to which she held several management posts at Affymetrix. Li, who will be Verinata's director of bioinformatics, was associate director of bioinformatics at Genomic Health, and worked previously at Ingenuity Systems and Novartis.


Lophius Biosciences has hired Karl Kleine as head of quality management and Kornelia Schlombs to serve as scientific project manager for molecular biology.

Kleine formerly was involved in quality management at Cogenics, and before that he worked at Epidauros Biotechnologies. Schlombs previously was in charge of genotyping studies at Epidauros.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.